Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Three-stage contingent screening for Down syndrome.

Dave Wright1, Ian Bradbury, Howard Cuckle

  • 1Department of Mathematics and Statistics, University of Plymouth, UK. dave.wright@plymouth.ac.uk

Prenatal Diagnosis
|April 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Designation of small for gestational age according to seven fetal growth charts in England's National Health Service: population based cohort study of 3.2 million births.

BMJ (Clinical research ed.)·2026
Same author

Improving detection and management of restricted fetal growth to prevent perinatal death.

BMJ (Clinical research ed.)·2026
Same author

INTERGROWTH 21st versus GROW fundal height charts and antenatal detection of small-for-gestational age: A multicenter cohort study.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

The Variation in IRT in Different Ethnic Groups in England-Implications for a Newborn Screening Programme for CF in Diverse Multiethnic Populations.

International journal of neonatal screening·2026
Same author

Genetic divergence of farmed Atlantic halibut (Hippoglossus hippoglossus) and potential for impact on wild populations.

BMC research notes·2026
Same author

Ultrasound and SNP-based cell-free DNA zygosity testing in twin pregnancies.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2026

A three-stage screening approach shows high potential for accurately detecting Down syndrome. This method aims for nearly 90% detection rates with less than 2% false positives, improving prenatal screening effectiveness.

Area of Science:

  • Prenatal diagnostics
  • Genetics
  • Maternal-fetal medicine

Background:

  • Down syndrome screening is crucial for early intervention.
  • Current screening methods have limitations in detection rates and false positives.

Purpose of the Study:

  • To evaluate a novel three-stage sequential screening protocol for Down syndrome.
  • To estimate the detection and false-positive rates of this multi-stage approach.

Main Methods:

  • Utilized maternal serum markers: pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (hCG) in the first trimester.
  • Incorporated nuchal translucency (NT) measurement for risk reassessment.
  • Integrated second-trimester markers (alpha-fetoprotein, unconjugated estriol, inhibin-A) for intermediate-risk pregnancies.

Related Experiment Videos

  • Employed multivariate Gaussian modeling and Monte Carlo simulation for rate estimation.

    • Main Results:

    • Projected overall detection rates approaching 90% with adherence to the three-stage policy.
    • Estimated false-positive rates below 2.0%.
    • Over 60% detection rate in the first trimester, with most women completing screening early.

    Conclusions:

    • The three-stage contingent sequential screening strategy demonstrates significant potential for effective Down syndrome detection.
    • Prospective studies are recommended to validate the protocol's real-world performance and acceptability.